EPIZYME INC (EPZM) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:EPZM • US29428V1044

1.47 USD
-0.02 (-1.34%)
At close: Aug 11, 2022
1.47 USD
0 (0%)
After Hours: 8/11/2022, 8:00:01 PM
Fundamental Rating

2

EPZM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. EPZM may be in some trouble as it scores bad on both profitability and health. EPZM is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • EPZM had negative earnings in the past year.
EPZM Yearly Net Income VS EBIT VS OCF VS FCFEPZM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -50M -100M -150M -200M -250M

1.2 Ratios

Industry RankSector Rank
ROA -78.64%
ROE N/A
ROIC -67.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EPZM Yearly ROA, ROE, ROICEPZM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 200 400 600 800 1K

1.3 Margins

Industry RankSector Rank
OM -370.05%
PM (TTM) -391.89%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPZM Yearly Profit, Operating, Gross MarginsEPZM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -500 -1K

More info and screens

2

2. Health

2.1 Basic Checks

  • EPZM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for EPZM has been increased compared to 1 year ago.
  • EPZM has a worse debt/assets ratio than last year.
EPZM Yearly Shares OutstandingEPZM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
EPZM Yearly Total Debt VS Total AssetsEPZM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

  • EPZM has an Altman-Z score of -8.10. This is a bad value and indicates that EPZM is not financially healthy and even has some risk of bankruptcy.
  • A Debt/Equity ratio of -11.48 indicates that EPZM is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -11.48
Debt/FCF N/A
Altman-Z -8.1
ROIC/WACC-5.62
WACC12.02%
EPZM Yearly LT Debt VS Equity VS FCFEPZM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M -100M 200M -200M 300M

2.3 Liquidity

  • A Current Ratio of 5.35 indicates that EPZM has no problem at all paying its short term obligations.
  • A Quick Ratio of 5.19 indicates that EPZM has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 5.35
Quick Ratio 5.19
EPZM Yearly Current Assets VS Current LiabilitesEPZM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

  • EPZM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
  • The Revenue has grown by 62.65% in the past year. This is a very strong growth!
  • The Revenue has been growing by 36.12% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)62.65%
Revenue growth 3Y19.92%
Revenue growth 5Y36.12%
Sales Q2Q%111.59%

3.2 Future

  • Based on estimates for the next years, EPZM will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.01% on average per year.
  • Based on estimates for the next years, EPZM will show a very strong growth in Revenue. The Revenue will grow by 57.70% on average per year.
EPS Next Y43.15%
EPS Next 2Y23.07%
EPS Next 3Y16.89%
EPS Next 5Y8.01%
Revenue Next Year28.63%
Revenue Next 2Y45.71%
Revenue Next 3Y52.93%
Revenue Next 5Y57.7%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EPZM Yearly Revenue VS EstimatesEPZM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
EPZM Yearly EPS VS EstimatesEPZM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EPZM. In the last year negative earnings were reported.
  • Also next year EPZM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EPZM Price Earnings VS Forward Price EarningsEPZM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.76
EPZM Per share dataEPZM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

  • EPZM's earnings are expected to grow with 16.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.07%
EPS Next 3Y16.89%

More info and screens

0

5. Dividend

5.1 Amount

  • EPZM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EPIZYME INC / EPZM FAQ

What is the fundamental rating for EPZM stock?

ChartMill assigns a fundamental rating of 3 / 10 to EPZM.


Can you provide the valuation status for EPIZYME INC?

ChartMill assigns a valuation rating of 0 / 10 to EPIZYME INC (EPZM). This can be considered as Overvalued.


Can you provide the profitability details for EPIZYME INC?

EPIZYME INC (EPZM) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for EPZM stock?

The Earnings per Share (EPS) of EPIZYME INC (EPZM) is expected to grow by 43.15% in the next year.